Atig, Juvy .

HRN: 11-60-96  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/17/2023
CEFUROXIME 1.5GM (VIAL)
01/17/2023
01/18/2023
IV
1.5 G
Q8 X 2 Doses
Sp Ltcs For Malpresentation
Waiting Final Action 
01/17/2023
CEFUROXIME 500MG (TAB)
01/19/2023
01/25/2023
ORAL
500mg
BID
Sp Ltcs For Malpresentation
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: